Sunmax Biotechnology Co Ltd (4728) — Cash Flow-to-Debt Ratio
Sunmax Biotechnology Co Ltd (4728) has a Cash Flow-to-Debt Ratio of 0.35x as of September 2025, meaning its operating cash flow of NT$160.84 Million could theoretically repay 0% of its total liabilities (NT$454.35 Million) in one year. Explore Sunmax Biotechnology Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sunmax Biotechnology Co Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Sunmax Biotechnology Co Ltd across 10 annual periods. Also explore balance sheet size of Sunmax Biotechnology Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sunmax Biotechnology Co Ltd (2015–2024)
Year-by-year debt coverage analysis for Sunmax Biotechnology Co Ltd. For market capitalisation and broader financial context, see market value of Sunmax Biotechnology Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.18x | NT$397.37 Million | NT$337.82 Million | ▲ +1.6% |
| 2023 | 1.16x | NT$848.56 Million | NT$732.99 Million | ▲ +58.0% |
| 2022 | 0.73x | NT$342.97 Million | NT$468.00 Million | ▲ +38.7% |
| 2021 | 0.53x | NT$243.28 Million | NT$460.44 Million | ▼ -35.1% |
| 2020 | 0.81x | NT$386.97 Million | NT$475.27 Million | ▲ +22.6% |
| 2019 | 0.66x | NT$289.51 Million | NT$435.82 Million | ▼ -27.6% |
| 2018 | 0.92x | NT$100.83 Million | NT$109.88 Million | ▲ +118.2% |
| 2017 | 0.42x | NT$37.09 Million | NT$88.22 Million | ▲ +7.0% |
| 2016 | 0.39x | NT$16.58 Million | NT$42.20 Million | ▲ +176.3% |
| 2015 | -0.52x | NT$-22.84 Million | NT$44.33 Million | — |